Literature DB >> 17093395

Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis.

Charlotte Andrieu-Soler1, Marc Doat, Mounia Halhal, Nicole Keller, Laurent Jonet, David BenEzra, Francine Behar-Cohen.   

Abstract

PURPOSE: To study the combination of oligodeoxynucleotides (ODNs) intravitreous injection and saline transpalpebral iontophoresis on the delivery of ODNs to photoreceptors in the newborn rd1/rd1 mice.
METHODS: Cathodal or anodal transpalpebral iontophoresis (1.43 mA/cm(2) for 5 min) was applied to eyes of postnatal day 7 (PN7) rd1/rd1 mice immediately before the intravitreous injection of ODNs. The effect of cathodal iontophoresis after ODNs injection was also evaluated. The influence of current intensity (0.5, 1.5, and 2.5 mA) was assayed with cathodal iontophoresis performed prior to ODNs injection. The duration of current-induced facilitation of ODNs delivery to photoreceptors was evaluated for 6 h following iontophoresis. One group of control eyes received cathodal iontophoresis prior to the intravitreous injection of phosphate buffered saline (PBS) or hexachlorofluorescein (Hex). The second control group received ODN or Hex intravitreous injection without iontophoresis. The penetration of fluorescent ODNs in the outer nuclear layer (ONL) was quantified by image analysis of the ONL fluorescence intensity on cryosection microphotographs. Integrity of ODN was assessed using acrylamide gel migration after its extraction from the retina of treated mice. The integrity of retinal structure, 1 and 24 h after iontophoresis, was analyzed using light and electron microscopy.
RESULTS: Transpalpebral anodal or cathodal saline iontophoresis enhanced the penetration of ODNs in all retinal layers. Cathodal iontophoresis was more efficient than anodal iontophoresis in enhancing the tissue penetration of the injected ODN. Photoreceptor delivery of ODN was significantly higher when cathodal saline transpalpebral iontophoresis was applied prior than after the injection. The extent of enhanced tissue penetration decreased in parallel to the increased interval between iontophoresis application and the intravitreous injection. Current of 1.5 mA was safe and optimal for the delivery of ODNs to the ONL. One hour after iontophoresis followed by injection, ODN extracted from the retina of treated eyes remained intact. Histology and electron microscopy observations demonstrated that iontophoresis using the optimal parameters did not induce any permanent tissue alterations or structure damage.
CONCLUSIONS: Saline transpalpebral iontophoresis facilitates the penetration of injected ODNs in photoreceptors for at least 3 h. This method may be considered for photoreceptor targeted gene therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17093395

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  10 in total

Review 1.  Nanoparticles for retinal gene therapy.

Authors:  Shannon M Conley; Muna I Naash
Journal:  Prog Retin Eye Res       Date:  2010-05-07       Impact factor: 21.198

Review 2.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

Review 3.  Stem cell transplantation as a progressing treatment for retinitis pigmentosa.

Authors:  Sedighe Hosseini Shabanan; Homa Seyedmirzaei; Alona Barnea; Sara Hanaei; Nima Rezaei
Journal:  Cell Tissue Res       Date:  2022-01-10       Impact factor: 5.249

Review 4.  Ocular Barriers and Their Influence on Gene Therapy Products Delivery.

Authors:  Bastien Leclercq; Dan Mejlachowicz; Francine Behar-Cohen
Journal:  Pharmaceutics       Date:  2022-05-06       Impact factor: 6.525

5.  Examination of barriers and barrier alteration in transscleral iontophoresis.

Authors:  Sarah A Molokhia; Eun-Kee Jeong; William I Higuchi; S Kevin Li
Journal:  J Pharm Sci       Date:  2008-02       Impact factor: 3.534

6.  In vitro extraction of intra-corneal iron using reverse iontophoresis and vitamin C.

Authors:  Jian-Hai Bai; Sheng Su; Lei Huang; Yan-Yan Zhang; Yun-Song Wang; Mei-Hua Guo; Hong-Bin Yang; Hao Cui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-06-05       Impact factor: 3.117

7.  A Solution to the Common Problem of the Synthesis and Applications of Hexachlorofluorescein Labeled Oligonucleotides.

Authors:  Andrey N Chuvilin; Igor P Smirnov; Alena G Mosina; Anna M Varizhuk; Galina E Pozmogova
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

8.  Trans-ocular Electric Current In Vivo Enhances AAV-Mediated Retinal Gene Transduction after Intravitreal Vector Administration.

Authors:  Hongman Song; Ronald A Bush; Yong Zeng; Haohua Qian; Zhijian Wu; Paul A Sieving
Journal:  Mol Ther Methods Clin Dev       Date:  2018-12-21       Impact factor: 6.698

9.  Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina.

Authors:  Charlotte Andrieu-Soler; Mounia Halhal; Jeffrey H Boatright; Staci A Padove; John M Nickerson; Eva Stodulkova; Rachael E Stewart; Vincent T Ciavatta; Marc Doat; Jean-Claude Jeanny; Therèse de Bizemont; Florian Sennlaub; Yves Courtois; Francine Behar-Cohen
Journal:  Mol Vis       Date:  2007-05-02       Impact factor: 2.367

Review 10.  Delivery is key: lessons learnt from developing splice-switching antisense therapies.

Authors:  Caroline Godfrey; Lourdes R Desviat; Bård Smedsrød; France Piétri-Rouxel; Michela A Denti; Petra Disterer; Stéphanie Lorain; Gisela Nogales-Gadea; Valentina Sardone; Rayan Anwar; Samir El Andaloussi; Taavi Lehto; Bernard Khoo; Camilla Brolin; Willeke Mc van Roon-Mom; Aurélie Goyenvalle; Annemieke Aartsma-Rus; Virginia Arechavala-Gomeza
Journal:  EMBO Mol Med       Date:  2017-05       Impact factor: 12.137

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.